Section Arrow
DCTH.NASDAQ
- Delcath Systems
Quotes are at least 15-min delayed:2026/11/20 17:54 EST
After Hours
Last
 18.6937
-0.0963 (-0.51%)
Bid
18.75
Ask
19.75
High 19.7675 
Low 18.5 
Volume 6.17K 
Regular Hours (Closed)
Last
 18.79
-0.45 (-2.34%)
Day High 
19.345 
Prev. Close
19.24 
1-M High
22.51 
Volume 
592.12K 
Bid
18.75
Ask
19.75
Day Low
18.51 
Open
18.89 
1-M Low
13.91 
Market Cap 
669.32M 
Currency 美元 
P/E 120.25 
%Yield -- 
10-SMA 19.72 
20-SMA 17.12 
50-SMA 16.16 
52-W High 22.51 
52-W Low 8.485 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.16/0.42
Enterprise Value
670.16M
Balance Sheet
Book Value Per Share
3.84
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
85.23M
Operating Revenue Per Share
0.08
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 42.3233 +0.3433 +0.82%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.65 +0.02 +1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.52 -0.42 -0.42%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.93 +0.021 +2.31%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 103.53 +0.53 +0.51%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.